Use of Enalapril to Prevent Myointimal Hyperplasia in Upper Extremity Arteriovenous Fistula for Hemodialysis Access: A Descriptive, Longitudinal, Cross-sectional, Case-control Study

Authors

  • Javier Ismael Hernández-Vázquez PueblaMed Medical Group in Puebla, Mexico.
  • Héctor Bizueto-Rosas Vascular Surgery and Angiology Department, Specialties Hospital, “La Raza” National Medical Center, Mexican Institute of Social Security, México City, México.
  • Pablo Martín Boada Sandoval Vascular Surgery and Angiology Department, Specialties Hospital, “La Raza” National Medical Center, Mexican Institute of Social Security, México City, México.

DOI:

https://doi.org/10.9734/bpi/cimms/v10/3838C

Keywords:

Myointimal hyperplasia, arteriovenous fistula, Enalapril, hemodialysis

Abstract

This chapter aims to evaluate the effect of Enalapril in preventing Myointimal Hyperplasia (MIH) in arm’s arteriovenous fistula (AVF) for hemodialysis access. The current descriptive, longitudinal, cross-sectional case-control study was carried out in our hospital by the vascular surgery service in partnership with the radiology service from January to May of 2017. In our study main causes of early AVF thrombosis, were diabetes and active smoking; also presenting higher MIH within those patients. Our findings on Enalapril as a risk factor for MIH are inconclusive, yet patients in the Enalapril group had lower myointimal complex measurements and less AVF early failure.

Published

2022-12-10

How to Cite

Javier Ismael Hernández-Vázquez, Héctor Bizueto-Rosas, & Pablo Martín Boada Sandoval. (2022). Use of Enalapril to Prevent Myointimal Hyperplasia in Upper Extremity Arteriovenous Fistula for Hemodialysis Access: A Descriptive, Longitudinal, Cross-sectional, Case-control Study. Current Innovations in Medicine and Medical Science Vol. 10, 50–57. https://doi.org/10.9734/bpi/cimms/v10/3838C

Issue

Current Innovations in Medicine and Medical Science Vol. 10

Section

Chapters